Sublocade.com
Find a SUBLOCADE ® Treatment Provider*
WebBefore you continue, please review the following information. This free tool provides a list of physicians, nurse practitioners, and physician assistants (hereafter collectively and individually referred to as HCP(s) or Healthcare Providers) who have the required legal permissions to treat opioid dependence with FDA-approved medications, have …
Actived: 1 days ago
Frequently Asked Questions
WebINDICATION: SUBLOCADE ® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is for adults with moderate to severe opioid addiction whose withdrawal symptoms are controlled by oral buprenorphine for at least 7 days. READ MORE FOR FULL INDICATION. INDICATION: SUBLOCADE ® (buprenorphine extended …
Treating Your Disease
WebINDICATION: SUBLOCADE ® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is for adults with moderate to severe opioid addiction whose withdrawal symptoms are controlled by oral buprenorphine for at least 7 days. READ MORE FOR FULL INDICATION. INDICATION: SUBLOCADE ® (buprenorphine extended …
How SUBLOCADE works
WebINDICATION: SUBLOCADE ® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is for adults with moderate to severe opioid addiction whose withdrawal symptoms are controlled by oral buprenorphine for at least 7 days. READ MORE FOR FULL INDICATION. INDICATION: SUBLOCADE ® (buprenorphine extended …
SUBLOCADE 7 days. SUBLOCADE is part of a complete …
WebSUBLOCADE Education Brochure | SUBLOCADE® (buprenorphine extended-release) injection, for subcutaneous use (CIII) SUBLOCADE ® (buprenorphine extended-release) injection, for subcutaneous use, CIII, is a prescription medicine used to treat adults
Patient Information for SUBLOCADE® (buprenorphine extended …
WebINDICATION: SUBLOCADE ® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is for adults with moderate to severe opioid addiction whose withdrawal symptoms are controlled by oral buprenorphine for at least 7 days. READ MORE FOR FULL INDICATION. INDICATION: SUBLOCADE ® (buprenorphine extended …
Information for Caregivers
WebBefore you continue, please review the following information. This free tool provides a list of physicians, nurse practitioners, and physician assistants (hereafter collectively and individually referred to as HCP(s) or Healthcare Providers) who have the required legal permissions to treat opioid dependence with FDA-approved medications, have …
Starting Treatment With SUBLOCADE® (buprenorphine extended …
WebINDICATION: SUBLOCADE ® (buprenorphine extended-release) injection, for subcutaneous use (CIII) is for adults with moderate to severe opioid addiction whose withdrawal symptoms are controlled by oral buprenorphine for at least 7 days. READ MORE FOR FULL INDICATION. INDICATION: SUBLOCADE ® (buprenorphine extended …
What to Expect Video Transcript
WebWhat to Expect Video Transcript [ON-SCREEN TEXT] OPIOID ADDICTION AND YOU. INDICATION: SUBLOCADE ® (buprenorphine extended-release) is a prescription medicine used to treat adults with moderate to severe addiction (dependence) to opioid drugs (prescription or illegal) who have received an oral transmucosal (used under the tongue …
Prescribing Information
Web4 consider prescribing naloxone if the patient has household members (including children) or other close contacts at risk for accidental ingestion or opioid overdose [see Warnings and Precautions (5.4)]. Advise patients and caregivers that naloxone may also be administered for a known or suspected
Out-of-Pocket Cost Savings
WebYou could pay between $.02 – $1,607 per dose (whether 300 mg or 100 mg) † if you are receiving SUBLOCADE once monthly (depending on your specific Medicare benefits), with the average out-of-pocket cost of SUBLOCADE itself being $97. † If you have Medicare Part B, you may also have a supplemental insurance plan that will pay all or part of your …
Preparing for Treatment With SUBLOCADE® (buprenorphine …
WebBefore you continue, please review the following information. This free tool provides a list of physicians, nurse practitioners, and physician assistants (hereafter collectively and individually referred to as HCP(s) or Healthcare Providers) who have the required legal permissions to treat opioid dependence with FDA-approved medications, have …
Treatment Plan With SUBLOCADE® (buprenorphine extended …
WebSUBLOCADE and treatment success* In a clinical study, SUBLOCADE patients were 14x * more likely to achieve treatment success. * 28% of people with SUBLOCADE plus counseling compared to 2% of people with placebo plus counseling. † In a 24-week study, treatment success was defined as opioid-free at least 80% of the weeks in treatment. …
Top Categories
Popular Searched
› Orlando health emergency room map
› Private healthcare systems insurance
› Free health and safety template
› Hawkes bay district health board course
› Oral health foundation poster download
› Health park endoscopy center reviews
› Oral health promotion program examples
› Intermountain health care employee email
› Personal health and hygiene lesson plans
Recently Searched
› Ascension health care location list
› Healthy living james allergy recipes
› Hosa home health aide responsibilities
› Behavioral health services inc
› Mental health working remotely
› Lexington county health care shortage
› Consociate health services decatur il
› Translational health sciences courses